Literature DB >> 29202449

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

Erica L Eggers, Brady A Michel, Hao Wu, Sheng-Zhi Wang, Carolyn J Bevan, Aya Abounasr, Natalie S Pierson, Antje Bischof, Max Kazer, Elizabeth Leitner, Ariele L Greenfield, Stanislas Demuth, Michael R Wilson, Roland G Henry, Bruce Ac Cree, Stephen L Hauser, H-Christian von Büdingen.   

Abstract

A role of B cells in multiple sclerosis (MS) is well established, but there is limited understanding of their involvement during active disease. Here, we examined cerebrospinal fluid (CSF) and peripheral blood (PB) B cells in treatment-naive patients with MS or high-risk clinically isolated syndrome. Using flow cytometry, we found increased CSF lymphocytes with a disproportionate increase of B cells compared with T cells in patients with gadolinium-enhancing (Gd+) lesions on brain MRI. Ig gene heavy chain variable region (Ig-VH) repertoire sequencing of CSF and PB B cells revealed clonal relationships between intrathecal and peripheral B cell populations, which could be consistent with migration of B cells to and activation in the CNS in active MS. In addition, we found evidence for bystander immigration of B cells from the periphery, which could be supported by a CXCL13 gradient between CSF and blood. Understanding what triggers B cells to migrate and home to the CNS may ultimately aid in the rational selection of therapeutic strategies to limit progression in MS.

Entities:  

Keywords:  Autoimmunity; B cells; Multiple sclerosis; Neuroscience

Mesh:

Substances:

Year:  2017        PMID: 29202449      PMCID: PMC5752381          DOI: 10.1172/jci.insight.92724

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  49 in total

1.  The risk of relapses in multiple sclerosis during systemic infections.

Authors:  Jorge Correale; Marcela Fiol; Wendy Gilmore
Journal:  Neurology       Date:  2006-07-26       Impact factor: 9.910

2.  Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts.

Authors:  Kimberly M Winges; Donald H Gilden; Jeffrey L Bennett; Xiaoli Yu; Alanna M Ritchie; Gregory P Owens
Journal:  J Neuroimmunol       Date:  2007-11-13       Impact factor: 3.478

3.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

4.  Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.

Authors:  Eduardo Beltrán; Birgit Obermeier; Markus Moser; Francisco Coret; María Simó-Castelló; Isabel Boscá; Francisco Pérez-Miralles; Luisa M Villar; Makbule Senel; Hayrettin Tumani; Reinhard Hohlfeld; Bonaventura Casanova; Klaus Dornmair
Journal:  Brain       Date:  2014-07-23       Impact factor: 13.501

5.  Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.

Authors:  Per S Sorensen; Steen Lisby; Richard Grove; Frederick Derosier; Steve Shackelford; Eva Havrdova; Jelena Drulovic; Massimo Filippi
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

6.  MiXCR: software for comprehensive adaptive immunity profiling.

Authors:  Dmitriy A Bolotin; Stanislav Poslavsky; Igor Mitrophanov; Mikhail Shugay; Ilgar Z Mamedov; Ekaterina V Putintseva; Dmitriy M Chudakov
Journal:  Nat Methods       Date:  2015-05       Impact factor: 28.547

7.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands".

Authors:  Hans-Christian von Büdingen; Monica Gulati; Sandra Kuenzle; Katja Fischer; Tobias A Rupprecht; Norbert Goebels
Journal:  J Neuroimmunol       Date:  2009-11-08       Impact factor: 3.478

9.  Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

Authors:  Kathleen Hawker; Paul O'Connor; Mark S Freedman; Peter A Calabresi; Jack Antel; Jack Simon; Stephen Hauser; Emmanuelle Waubant; Timothy Vollmer; Hillel Panitch; Jiameng Zhang; Peter Chin; Craig H Smith
Journal:  Ann Neurol       Date:  2009-10       Impact factor: 10.422

10.  B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.

Authors:  Joel N H Stern; Gur Yaari; Jason A Vander Heiden; George Church; William F Donahue; Rogier Q Hintzen; Anita J Huttner; Jon D Laman; Rashed M Nagra; Alyssa Nylander; David Pitt; Sriram Ramanan; Bilal A Siddiqui; Francois Vigneault; Steven H Kleinstein; David A Hafler; Kevin C O'Connor
Journal:  Sci Transl Med       Date:  2014-08-06       Impact factor: 17.956

View more
  27 in total

Review 1.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

2.  Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Authors:  Ariele L Greenfield; Ravi Dandekar; Akshaya Ramesh; Erica L Eggers; Hao Wu; Sarah Laurent; William Harkin; Natalie S Pierson; Martin S Weber; Roland G Henry; Antje Bischof; Bruce Ac Cree; Stephen L Hauser; Michael R Wilson; H-Christian von Büdingen
Journal:  JCI Insight       Date:  2019-03-21

3.  Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.

Authors:  Nabila Belhouachi; Aliki Xochelli; Myriam Boudjoghra; Claude Lesty; Nathalie Cassoux; Christine Fardeau; Thi Ha Chau Tran; Sylvain Choquet; Bishnu Sarker; Caroline Houillier; Agusti Alentorn; Phuc LeHoang; Carole Soussain; Valerie Touitou; Helene Merle-Beral; Khe Hoang-Xuan; Bahram Bodaghi; Kostas Stamatopoulos; Frederic Davi
Journal:  Blood Adv       Date:  2020-04-14

Review 4.  B-cell Therapy for Multiple Sclerosis: Entering an era.

Authors:  Ariele L Greenfield; Stephen L Hauser
Journal:  Ann Neurol       Date:  2018-01       Impact factor: 10.422

Review 5.  Understanding and measuring human B-cell tolerance and its breakdown in autoimmune disease.

Authors:  Kevin S Cashman; Scott A Jenks; Matthew C Woodruff; Deepak Tomar; Christopher M Tipton; Christopher D Scharer; F Eun-Hyung Lee; Jeremy M Boss; Iñaki Sanz
Journal:  Immunol Rev       Date:  2019-11-22       Impact factor: 12.988

6.  Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes.

Authors:  Samantha S Soldan; Chenhe Su; R Jason Lamontagne; Nicholas Grams; Fang Lu; Yue Zhang; James D Gesualdi; Drew M Frase; Lois E Tolvinski; Kayla Martin; Troy E Messick; Jonathan T Fingerut; Ekaterina Koltsova; Andrew Kossenkov; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2021-06-09       Impact factor: 6.823

Review 7.  The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Authors:  Caterina Veroni; Francesca Aloisi
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

8.  Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.

Authors:  Hanane Touil; Antonia Kobert; Nathalie Lebeurrier; Aja Rieger; Philippe Saikali; Caroline Lambert; Lama Fawaz; Craig S Moore; Alexandre Prat; Jennifer Gommerman; Jack P Antel; Yasuto Itoyama; Ichiro Nakashima; Amit Bar-Or
Journal:  J Neuroinflammation       Date:  2018-04-19       Impact factor: 8.322

Review 9.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26

10.  Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.

Authors:  Bryan Ceronie; Benjamin M Jacobs; David Baker; Nicolas Dubuisson; Zhifeng Mao; Francesca Ammoscato; Helen Lock; Hilary J Longhurst; Gavin Giovannoni; Klaus Schmierer
Journal:  J Neurol       Date:  2018-03-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.